Jagsonpal Pharmaceuticals Limited
JAGSNPHARM · NSE · ₹232 a share (close of 01 Oct 2026)
Available company data, source links and archived checks for Jagsonpal Pharmaceuticals Limited. Read each source and date: a past check is not a fresh review, and some earlier figures have incomplete source details.
Revenue rose 8.8%; Net profit was ₹13.19 crore.
Quarter ended 2026-06-30 · standalone · Company filing
Recorded quarterly figures
| Quarter | Revenue / income | YoY |
Profit | YoY | Net margin | Source |
|---|
| Jun 2026 | Revenue: ₹82 cr | +8.8% | Net profit: ₹13 cr | +22.2% | 16.0% | Company filing source |
| Mar 2026 | Revenue: ₹64 cr | +9.6% | Net profit: ₹9 cr | +33.1% | 13.6% | Company filing source |
| Dec 2025 | Revenue: ₹73 cr | — | Net profit: ₹11 cr | — | 15.0% | Company filing source |
| Sep 2025 | Revenue: ₹74 cr | — | Net profit: ₹13 cr | — | 16.9% | Company filing source |
| Jun 2025 | Revenue: ₹76 cr | +23.1% | Net profit: ₹11 cr | +102.6% | 14.3% | Company filing source |
| Mar 2025 | Revenue: ₹59 cr | — | Net profit: ₹7 cr | — | 11.2% | Company filing source |
YoY means change from the same quarter a year earlier.
— means no comparable figure is available. Older entries with incomplete source
details have not been revalidated under the current checks.
Who holds it — from the filings
Aresko Progressive Private Limited (Trustee of Aresko Progressive Trust, a in the capacity of representative partner of J&P Investments Partnership) 20.3%INFINITY CAPITAL (Formerly Infinity Holdings Sidecar1) 18.1%INFINITY HOLDINGS 16.8%INFINITY PORTFOLIO HOLDINGS 8.7%RAJPAL SINGH KOCHHAR 4.6%register as filed
2026-06-30
Filing timeline — what the company told the exchange
- Jagsonpal Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication…
30 Sep 2026 · document
- Updates. Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding 'Allotment of 101825 Equity Shares under the Jagsonpal Pharmaceuticals Limited Em…
30 Sep 2026 · document
- Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, …
25 Sep 2026 · document
- Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 23, 2026, titled "Press Release on Acquisition of the well…
23 Sep 2026 · document
- General Updates. Jagsonpal Pharmaceuticals Limited has informed the Exchange about the Acquisition of Wellness Portfolio of Group Pharmaceuticals Limited.…
23 Sep 2026 · document
- Shareholders meeting. Jagsonpal Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 18, 202…
21 Sep 2026 · document
- Jagsonpal Pharmaceuticals Limited has informed the Exchange about Shareholders meeting…
18 Sep 2026 · document
- Jagsonpal Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication…
28 Aug 2026 · document
Follow this company without reading every document yourself.
Keep its available filings, dated fact checks and disclosure alerts together.
Your saved country sets your market and its research schedule.
Start free — first week on us →
India ₹149/month · Rest of world US$4.99/month after the free trial · research, not investment
advice · cancel any time